FranΓ§aisπ See the interactive version (live chart) β
For Healthcare Realty Trust, we replayed every analyst price target of the past 12 months and measured the real outcome: 46% were profitable, average return +2% (11 calls). At 3 months: +3% average return (35% profitable). The higher the %, the more often analysts were right on this stock.
Their past track record on this stock (targets replayed against real prices) β not a forecast of what will happen.
Not enough scored calls for a reliable ranking.
π΅ Dividend : Healthcare Realty Trust pays about $0.96/share/yr β 4.73% yield. what is this?
The analyst consensus on Healthcare Realty Trust (HR) is "Hold" (8 bullish, 1 bearish calls over 12 months). This is not advice: historically, 46% of their targets on this stock turned out profitable over 1 year.
The median 12-month price target is $21.00 (+10% vs $19.13), ranging from $21.00 to $24.00 (7 analysts).
Over 1 year, 46% of analyst targets on Healthcare Realty Trust were profitable, for an average return of +2% (across 11 timestamped calls). This is JPI Invest's accuracy metric.
Analysts target a median of $21.00 within 12 months, i.e. +10% vs the current price. The most bullish targets $24.00, the most cautious $21.00.
Note: analyst targets are 12-month (median $21.00, +10%), NOT 2030. No reliable 5-10 year price forecast exists (Β« 2030 prediction Β» models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (46%), and the stock's past trajectory.
Detailed valuation data for Healthcare Realty Trust is available in the interactive analysis.
π See the full interactive analysis of Healthcare Realty Trust β
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.